In a regulatory filing, Amneal Pharmaceuticals (AMRX) director Gautam Patel disclosed the sale of 62,590 class A common shares of the company on January 8 at a price of $8.01 per share.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener